Bristol-Myers Squibb Company (
) will begin trading ex-dividend on April 02, 2014. A cash dividend
payment of $0.36 per share is scheduled to be paid on May 01, 2014.
Shareholders who purchased BMY stock prior to the ex-dividend date
are eligible for the cash dividend payment. This represents an
2.86% increase over the same period a year ago.
The previous trading day's last sale of BMY was $51.95,
representing a -9.64% decrease from the 52 week high of $57.49 and
a 32.59% increase over the 52 week low of $39.18.
BMY is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Novartis AG (
). BMY's current earnings per share, an indicator of a company's
profitability, is $1.55. Zacks Investment Research reports BMY's
forecasted earnings growth in 2014 as -2.83%, compared to an
industry average of -.6%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to BMY through an Exchange
Traded Fund [ETF]?
The following ETF(s) have BMY as a top-10 holding:
- iShares U.S. Pharmaceutical ETF (
- Merrill Lynch Pharmaceutical HOLDRS (
- PowerShares Dynamic Pharmaceuticals (
- Select Sector SPDR Fund - Health Care (
- Columbia Select Large Cap Value ETF (
The top-performing ETF of this group is PJP with an increase of
16.83% over the last 100 days. IHE has the highest percent
weighting of BMY at 7.27%.